Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Data may help cancer drug gain approval for wider use

Wall Street Journal (subscription required), December 11, 2007

Clinical-trial results showing that the blood-cancer drug Velcade increases remission rates in patients could boost its chances of winning regulatory approval for wider use. Velcade currently is approved in the United States to treat multiple myeloma in patients who have received at least one prior therapy.